Zydus Lifesciences has informed that it enclosed a copy of press release dated January 7, 2025, titled ‘Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM and ZituvimetTM XR (Sitagliptin Sitagliptin and Metformin Hydrochloride) to its template formulary’.
The above information is a part of company’s filings submitted to BSE.